“Newest Trends in Melanoma: Does Less Equal More?”

Friday, June 30, 2017

Walker Auditorium

12:30 p.m. – 1:30 p.m.

Lunch available on a first come, first served basis

Presented by:

Richard W. Joseph, M.D.

Hematology/Oncology

Mayo Clinic Florida

Learning Objectives:

Upon conclusion of this program, participants should be able to:

• Explain the role of completion lymph node dissection in patients with stage 3 melanoma.
• Explain the role of ipilimumab in the adjuvant setting for metastatic melanoma.
• Explain the efficacy of immunotherapy for brain metastases in melanoma.

  “Speaker, Doctor Richard Jospeh, has no financial relationships to disclose or intentions to discuss off-label/ investigational use of a commercial product device.”

  Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

  Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Please direct all inquiries for non-physician CEU’s to Clinical Education at (3-0326)

  For further information, contact  Jen Gatchell 3-2795